top of page
< Back

Risedronate


Mechanism of action:

Risedronate is a nitrogen-containing bisphosphonate derivative. Risedronate selectively binds to hydroxyapatite on the bone surface, especially at sites of active bone resorption. When osteoclasts resorb bone, risedronate is taken up into the cells along with the bone matrix. Inside osteoclasts, risedronate inhibits farnesyl pyrophosphate synthase and blocks the production of intermediates required for prenylation. When small GTP-binding proteins such as Ras, Rho, and Rab cannot undergo prenylation, multiple osteoclast metabolic processes are suppressed, ultimately leading to osteoclast apoptosis.

Reference(s):

1. Russell RG et al. (2008). Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 


2. Cremers S et al. (2019). Pharmacology of bisphosphonates. Br J Clin Pharmacol. 


3. Thompson Micromedex. (2004). Usp Vol I Drug Info Health Vol: Volume I (USP DI: v.1 Drug Information for the Health Care Professional) (24th ed., pp. 2475). Thompson PDR.

bottom of page